Literature DB >> 28445842

Βeta-eudesmol reduces stem cell factor-induced mast cell migration.

Sun-Young Nam1, Hee-Yun Kim1, Hyung-Min Kim2, Hyun-Ja Jeong3.   

Abstract

Previously, we showed the inhibitory effects of β-eudesmol on mast cell-mediated allergic inflammatory responses. Stem cell factor (SCF) participates in allergic reactions through the differentiation and migration of mast cells. However, the effects of β-eudesmol on SCF-mediated allergic reactions are poorly understood. Herein, we showed that a treatment of rat peritoneal mast cells (RPMCs) with β-eudesmol markedly suppressed SCF-induced mast cell migration and morphological alterations in a concentration-dependent manner. β-eudesmol also reduced F-actin formation. The activation of Fyn kinase, Rac1 GTPase, and p38 mitogen-activated protein kinases as increased by SCF was reduced by β-eudesmol. Moreover, β-eudesmol significantly abolished SCF-induced tumor necrosis factor-α and intercellular adhesion molecule-1 production without cytotoxicity. These results demonstrate that β-eudesmol has an anti-allergic inflammatory effect through the inhibition of mast cell migration and inflammatory cytokine production.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Allergic reaction; Mast cell; Migration; Stem cell factor; β-eudesmol

Mesh:

Substances:

Year:  2017        PMID: 28445842     DOI: 10.1016/j.intimp.2017.04.017

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma.

Authors:  Kanawut Kotawong; Wanna Chajaroenkul; Sittiruk Roytrakul; Narumon Phaonakrop; Kesara Na-Bangchang
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

Review 2.  The Role of Mast Cells in IgE-Independent Lung Diseases.

Authors:  Daniel Elieh Ali Komi; Esmaeil Mortaz; Saeede Amani; Angelica Tiotiu; Gert Folkerts; Ian M Adcock
Journal:  Clin Rev Allergy Immunol       Date:  2020-06       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.